You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

MDS-myeloproliferative neoplasm

Showing 1 - 25 of 1,958
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

MDS, Myeloproliferative Tumor, Anemia Trial in Tampa (Luspatercept)

Recruiting
  • Myelodysplastic Syndromes
  • +2 more
  • Tampa, Florida
    Moffitt Cancer Center
Feb 16, 2023

Myeloproliferative Tumor, Chronic Neutrophilic Leukemia, MDS Trial in Tampa (Fedratinib Pill)

Recruiting
  • Myeloproliferative Neoplasm
  • +2 more
  • Fedratinib Pill
  • Tampa, Florida
    Moffitt Cancer Center
Jun 15, 2022

Myelodysplastic/Myeloproliferative Tumor With Ring Sideroblasts and Thrombocytosis, Myelodysplastic/Myeloproliferative Tumor,

Recruiting
  • Myelodysplastic/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis
  • Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 6, 2023

Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome, Myelodysplastic Syndrome With Excess Blasts Trial (Biospecimen

Not yet recruiting
  • Chronic Myelomonocytic Leukemia
  • +3 more
  • Biospecimen Collection
  • +3 more
  • (no location specified)
Oct 27, 2022

MDS, Myeloproliferative Tumor Trial in United States (Azacitidine Subcutaneous Injection or Intravenous Infusion, Pevonedistat

Active, not recruiting
  • Myelodysplastic Syndromes
  • Myeloproliferative Neoplasm
  • Azacitidine Subcutaneous Injection or Intravenous Infusion
  • +2 more
  • Miami, Florida
  • +4 more
Jun 20, 2022

Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Myeloproliferative Tumor (MDS/MPN) Trial in Durham (ADCT-301)

Recruiting
  • Acute Myeloid Leukemia (AML)
  • +2 more
  • Durham, North Carolina
    Duke University Health System
Jan 10, 2022

Acute Myeloid Leukemia, Leukemia, Leukemia, Myeloid Trial in Boston (Cytokine Induced Memory-like Natural Killer Cells,

Not yet recruiting
  • Acute Myeloid Leukemia
  • +5 more
  • Cytokine Induced Memory-like Natural Killer Cells
  • Interleukin-2
  • Boston, Massachusetts
  • +1 more
Nov 14, 2023

Myelodysplastic/Myeloproliferative Tumor, Steroid Refractory GVHD, Allogeneic Hematopoietic Cell Transplant Trial in Toronto

Completed
  • Myelodysplastic/Myeloproliferative Neoplasm
  • +2 more
  • Decidual stromal cells (DSC)
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Jan 8, 2023

Myeloproliferative Tumor, Polycythemia Vera, Essential Thrombocythemia Trial in Hong Kong

Recruiting
  • Myeloproliferative Neoplasm
  • +7 more
    • Hong Kong, Hong Kong
      Department of Medicine, Queen Mary Hospital
    May 21, 2023

    Leukemia, Lymphoma, Multiple Myeloma Trial in Omaha (CHAMPS-II adapted to adults 60+ years in HCT setting, Survivorship

    Recruiting
    • Leukemia
    • +4 more
    • CHAMPS-II adapted to adults 60+ years in HCT setting
    • Survivorship education active control
    • Omaha, Nebraska
      University of Nebraska Medical Center
    Nov 26, 2021

    Acute Myeloid Leukemia, Acute Myeloid Leukemia With Multilineage Dysplasia, Chronic Myelomonocytic Leukemia Trial in Chapel

    Recruiting
    • Acute Myeloid Leukemia
    • +5 more
    • Biospecimen Collection
    • +3 more
    • Baltimore, Maryland
    • +2 more
    Jan 19, 2023

    Myelodysplastic/Myeloproliferative Tumor, Unclassifiable, Myelofibrosis Transformation in Essential Thrombocythemia,

    Recruiting
    • Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable
    • +3 more
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 18, 2022

    Clonal Cytopenia of Undetermined Significance, Essential Thrombocythemia, Myelodysplastic Syndrome Trial in Los Angeles

    Not yet recruiting
    • Clonal Cytopenia of Undetermined Significance
    • +4 more
    • Biospecimen Collection
    • +6 more
    • Los Angeles, California
    • +1 more
    Oct 4, 2023

    Iron Deficiency Anemia Trial in Australia, Israel, Romania (KER-047)

    Recruiting
    • Iron Deficiency Anemia
    • Adelaide, South Australia, Australia
    • +8 more
    Jun 23, 2023

    Myeloproliferative Tumor, Secondary Leukemia Trial (Multiomic characterization, In vitro drug screening)

    Not yet recruiting
    • Myeloproliferative Neoplasm
    • Secondary Leukemia
    • Multiomic characterization
    • In vitro drug screening
    • (no location specified)
    Aug 28, 2023

    MDS/MPN Trial in Nanjing (Azacitidine (AZA) with Ruxolitinib)

    Recruiting
    • MDS/MPN
    • Azacitidine (AZA) with Ruxolitinib
    • Nanjing, Jiangsu, China
      The First Affiliated Hospital of Nanjing Medical University
    Apr 17, 2023

    Action of Interferon in Treatment of Myeloproliferative

    Recruiting
    • Myeloproliferative Neoplasm
      • Villejuif, Ile De France, France
        Inserm U1287
      Apr 28, 2023

      MDS, Myeloproliferative Tumors, Myelofibrosis Trial (Jaktinib, azacitidine)

      Not yet recruiting
      • Myelodysplastic Syndromes
      • +2 more
      • (no location specified)
      Nov 29, 2021

      Myeloproliferative Disorders, Leukemia Trial in Boston (Cardiac Lifestyle Program)

      Not yet recruiting
      • Myeloproliferative Disorders
      • Leukemia
      • Cardiac Lifestyle Program
      • Boston, Massachusetts
      • +2 more
      May 1, 2023

      Acute Myeloid Leukemia, MDS, Myelodysplastic/Myeloproliferative Tumor Trial in Worldwide (BGB-11417, Azacitidine, Posaconazole)

      Recruiting
      • Acute Myeloid Leukemia
      • +2 more
      • Houston, Texas
      • +23 more
      Aug 18, 2022

      Epidemiological and Clinical-pathological Factors of

      Completed
      • Myeloproliferative Neoplasm
      • +4 more
        • Guayaquil, Guayas, Ecuador
          Sociedad de Lucha Contra el Cáncer
        Apr 25, 2023

        Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Blasts 10 Percent or More of Bone Marrow

        Recruiting
        • Acute Myeloid Leukemia
        • +6 more
        • Houston, Texas
          M D Anderson Cancer Center
        Jan 31, 2022

        Accelerated Phase MPN, Blast Phase MPN Trial (zelavespib)

        Withdrawn
        • Accelerated Phase MPN
        • Blast Phase MPN
        • (no location specified)
        Nov 4, 2022

        Acute Myeloid Leukemia in Remission, Chronic Myelomonocytic Leukemia, Minimal Residual Disease Trial in Seattle (procedure,

        Active, not recruiting
        Has Results
        • Acute Myeloid Leukemia in Remission
        • +5 more
        • Allogeneic Bone Marrow Transplantation
        • +5 more
        • Seattle, Washington
          Fred Hutch/University of Washington Cancer Consortium
        May 13, 2021

        Epigenetic Age on Clinic-biological Presentation and Prognosis

        Not yet recruiting
        • Myeloproliferative Neoplasm
        • Assessment of the epigenetic age
        • Bordeaux, France
          CHU de Bordeaux, service Hématologie Biologique
        Aug 28, 2023